FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daniel Stewart

Research Profile

Procedures

Concepts & Ideas

Disorders

Chemicals & Drugs

Living Beings

Arthrodermataceae

Anatomy

Skin

Co-author Network

Publications

TOP 3
David M Pariser; Nicholas J Lowe; Daniel M Stewart; Michael Jarratt; Anne W Lucky; Robert J Pariser; Paul S Yamauchi
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.
Anne W Lucky; JL Jorizzo; David Rodriguez; Terry M Jones; Daniel M Stewart; Eduardo Tschen; N B Kanof; BH Miller; David C Wilson; K H Loven
Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
John S Strauss; James J Leyden; Anne W Lucky; Donald P Lookingbill; LA Drake; Jon M Hanifin; Nicholas J Lowe; Terry M Jones; Daniel M Stewart; Michael Jarratt; Irving Katz; David M Pariser; Robert J Pariser; Eduardo Tschen; Daniel K Chalker; Elyse S Rafal; Ronald P Savin; Harry L Roth; Lawrence K Chang; DJ Baginski; Steven Kempers; John A McLane; Douglas R Eberhardt; EE Leach; Graeme F Bryce; J Hong
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daniel Stewart (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: David M Pariser; Nicholas J Lowe; Daniel M Stewart; Michael Jarratt; Anne W Lucky; Robert J Pariser; Paul S Yamauchi
Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.
Journal of the American Academy of Dermatology 2003;48(2):227-32.
2001: Anne W Lucky; JL Jorizzo; David Rodriguez; Terry M Jones; Daniel M Stewart; Eduardo Tschen; N B Kanof; BH Miller; David C Wilson; K H Loven
Efficacy and tolerance of adapalene cream 0.1% compared with its cream vehicle for the treatment of acne vulgaris.
Cutis; cutaneous medicine for the practitioner 2001;68(4 Suppl):34-40.
2001: John S Strauss; James J Leyden; Anne W Lucky; Donald P Lookingbill; LA Drake; Jon M Hanifin; Nicholas J Lowe; Terry M Jones; Daniel M Stewart; Michael Jarratt; Irving Katz; David M Pariser; Robert J Pariser; Eduardo Tschen; Daniel K Chalker; Elyse S Rafal; Ronald P Savin; Harry L Roth; Lawrence K Chang; DJ Baginski; Steven Kempers; John A McLane; Douglas R Eberhardt; EE Leach; Graeme F Bryce; J Hong
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Journal of the American Academy of Dermatology 2001;45(2):196-207.
2001: John S Strauss; James J Leyden; Anne W Lucky; Donald P Lookingbill; LA Drake; Jon M Hanifin; Nicholas J Lowe; Terry M Jones; Daniel M Stewart; Michael Jarratt; Irving Katz; David M Pariser; Robert J Pariser; Eduardo Tschen; Daniel K Chalker; Elyse S Rafal; Ronald P Savin; Harry L Roth; Lawrence K Chang; DJ Baginski; Steven Kempers; John A McLane; Douglas R Eberhardt; EE Leach; Graeme F Bryce; J Hong
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.
Journal of the American Academy of Dermatology 2001;45(2):187-95.
2001: James J Leyden; J G Hickman; Michael Jarratt; Daniel M Stewart; SF Levy
The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
Journal of cutaneous medicine and surgery 2001;5(1):37-42.
1998: Ronald Savin; LA Drake; DE Babel; Daniel M Stewart; Phoebe Rich; Mark R Ling; Debra L Breneman; Richard Scher; Ann Martin; David M Pariser; Robert J Pariser; Charles Ellis; Sewon Kang; D Friedman; H Irving Katz; CJ McDonald; JJ Muglia; Guy Webster; Boni E Elewski; James J Leyden; AD Bucko; Eduardo Tschen; Jon M Hanifin; Manuel Morman; J Hilbert
Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S110-6.
1998: Mark R Ling; Leonard J Swinyer; Michael Jarratt; L Falo; E W Monroe; M Tharp; J Kalivas; Gerald D Weinstein; R G Asarch; LA Drake; Ann Martin; James J Leyden; Joel Cook; David M Pariser; Robert J Pariser; Bruce H Thiers; Mark Lebwohl; DE Babel; Daniel M Stewart; W H Eaglstein; V Falanga; H Irving Katz; Wilma F Bergfeld; Jon M Hanifin; M R Young
Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S95-102.
1998: LA Drake; DE Babel; Daniel M Stewart; Phoebe Rich; Mark R Ling; Debra L Breneman; Richard Scher; Ann Martin; David M Pariser; Robert J Pariser; Charles Ellis; Sewon Kang; H Irving Katz; CJ McDonald; JJ Muglia; Ronald Savin; Guy Webster; Boni E Elewski; James J Leyden; AD Bucko; Eduardo Tschen; Jon M Hanifin; Manuel Morman; Jerome L Shupack; DL Greer
Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Journal of the American Academy of Dermatology 1998;38(6 Pt 2):S87-94.
1998: J M Maloney; Manuel Morman; Daniel M Stewart; M D Tharp; J J Brown; R Rajagopalan
Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
International journal of dermatology 1998;37(2):142-4.
1997: JL Jorizzo; K Magee; Daniel M Stewart; Mark Lebwohl; R Rajagopalan; J J Brown
Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasis.
Cutis; cutaneous medicine for the practitioner 1997;60(1):55-60.
1997: Jack L Lesher; DE Babel; Daniel M Stewart; Terry M Jones; L Kaminester; M Goldman; J S Weintraub
Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
Journal of the American Academy of Dermatology 1997;36(2 Pt 1):S20-4.